Tasuku Honjo
Annual Plan:2015-2020
Improvement of PD-1 antibody cancer immunotherapy
Prof. Tausku Honjo, the 2014 laureate, decided to dedicate his grand funds to the launch of “Improvement of PD-1(Programmed Death Cell Protein-1) Antibody Cancer Immunotherapy,” a cancer-fighting research project.